|Day's range||33.66 - 33.98|
|52-week range||25.55 - 35.60|
|PE ratio (TTM)||25.39|
|Dividend & yield||1.90 (5.67%)|
|1y target est||34.87|
AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).
Arena plans to offer and sell shares of its common stock worth $150 million, subject to customary closing conditions.